Skip to content

Research about diagnostic markers and mechanism of Babao Dan treating Minimal Hepatic Encephalopathy

Research about diagnostic markers and mechanism of Babao Dan treating Minimal Hepatic Encephalopathy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009588
Enrollment
Unknown
Registered
2016-10-25
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimal Hepatic Encephalopathy

Interventions

Sponsors

Shuguang Hospital affiliated to Shanghai university of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) The person who has hepatitis B, hepatitis C, alcohol, or autoimmune liver cirrhosis; 2) The person who doesn't have abnormal signs of clinical mental and nervous system disease; 3) The diagnosis of liver cirrhosis reference 2014 white paper on "China liver disease diagnosis and treatment management norms" (excerpts).

Exclusion criteria

Exclusion criteria: (1) The person who has hepatic encephalopathy in the last 6 months or now; (2) The person who takes lactulose, probiotics, or nmda ornithine for nearly three months, who uses antibiotics or sedatives nearly 1 week; (3) The person who has alcoholic liver cirrhosis and alcohol abuse nearly three months; (4) The person who has color blindness, cataracts, diabetes, or hypertension retinopathy, near vision disorder; (6) The person who has a history of mental illness, mental disease or nerve disease; (7) The person who has other metabolic disease, such as ketoacidosis, hypoglycemia, hyponatremia and renal encephalopathy, alcoholic encephalopathy, Pulmonary encephalopathy, wernicke encephalopathy; (8) acute poisoning, etc; (9) The person who has other systems such as heart, lung, and kidney of serious illness; (10) The person who doesn't cooperate with diagnosis and treatment.

Design outcomes

Primary

MeasureTime frame
Number connection test;Digit symbol test;Metabonomics;genomics;

Secondary

MeasureTime frame
Blood ammonia;

Countries

China

Contacts

Public ContactMingyu Sun

Shuguang Hospital, Shanghai University of TCM

mysun248@hotmail.com+86 13918746358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026